NCT02897401 (CANICE) is a NA clinical trial of pregnancy test in Smoking, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT02897401?

NCT02897401 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT02897401?

Interventions in NCT02897401: pregnancy test, urinary cotinine assesment, Urinary NNN assesement, Questionnaire (Fagerstrom test), Measurement of carbon monoxide levels expired.

What condition does NCT02897401 study?

NCT02897401 studies Smoking, Carcinogenesis of the Nicotine.

Is NCT02897401 still recruiting?

NCT02897401 is currently status unknown. Last updated 7 September 2016.

Last reviewed 2016-09-07 · How we verify

NCT02897401: CANICE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination of Carcinogens Nicotine in Electronic Cigarettes Users

Status unknown NA Last updated 7 September 2016

What this trial tests

NA trial testing pregnancy test in Smoking in 80 participants. Status unknown.

Timeline

1 September 2016

Primary endpoint
1 November 2017

1 November 2017

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	1 September 2016
Primary completion	1 November 2017
Estimated completion	1 November 2017
Sites	1 location across France

Drugs / interventions tested

pregnancy test — full drug profile →
urinary cotinine assesment — full drug profile →
Urinary NNN assesement — full drug profile →
Questionnaire (Fagerstrom test)
Measurement of carbon monoxide levels expired

Conditions studied

Smoking — all drugs for Smoking →
Carcinogenesis of the Nicotine — all drugs for Carcinogenesis of the Nicotine →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Smoking or Carcinogenesis of the Nicotine. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

NNN urinary concentrations obtained in the group "electronic cigarette" versus group "nocotine replacement treatment".
Time frame: At the inclusion
The determination of urinary NNN of will be performed at the end of the study only for subjects with cotinine / creatinine ratio adequate.

Sponsor's own description

Multicenter, national study, non-randomized , controlled, comparative with 4 independent groups (20 participants in each group). There are 3 experimental groups ("smocker", "nicotine replacement therapy" an "electronic cigarette") and 1 control group ("without nicotine"). The main objective of the study is to compare the level of urinary NNN in the electronic cigarette users versus the nicotine replacement therapy (patch) users.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of pregnancy test

Trials testing the same drug.

NCT06747598 — Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing · completed

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02897401 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 7 September 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02897401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing